Medpace Holdings, Inc. beat EPS estimates 100% of the time across 16 reported quarters (16 beats, 0 misses), averaging +15.3% versus consensus. Data sourced from SEC EDGAR.
| Quarter | EPS Estimate | EPS Actual | Surprise | Result | Call |
|---|---|---|---|---|---|
| Q2 FY26 | $4.08 | $4.25 | +4.2% | Beat | Q2 FY26 call |
| Q1 FY26 | $3.74 | $4.28 | +14.4% | Beat | |
| Q4 FY25 | $4.18 | $4.67 | +11.7% | Beat | Q4 FY25 call |
| Q3 FY25 | $3.50 | $3.86 | +10.3% | Beat | Q3 FY25 call |
| Q2 FY25 | $3.00 | $3.10 | +3.3% | Beat | Q2 FY25 call |
| Q1 FY25 | $3.06 | $3.67 | +19.9% | Beat | |
| Q4 FY24 | $2.97 | $3.67 | +23.6% | Beat | |
| Q3 FY24 | $2.77 | $3.01 | +8.7% | Beat | |
| Q2 FY24 | $2.52 | $2.75 | +9.1% | Beat | |
| Q1 FY24 | $2.45 | $3.20 | +30.6% | Beat | |
| Q4 FY23 | $2.23 | $2.46 | +10.3% | Beat | |
| Q3 FY23 | $2.04 | $2.22 | +8.8% | Beat |
Back to MEDP overview · MEDP holders · MEDP KPIs
Data sourced from U.S. SEC EDGAR filings. Not personalized investment advice.